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Introduction
Acral melanoma is a very rare variety of  cutaneous melanoma, it’ 
is defined as a melanoma located on the non-hair-bearing skin of  
the palms and soles or under the nails [1].  amelanotic malignant 
melanoma is sometimes misdiagnosed. The prognosis of  this 
tumor remains reserved. We report the epidemiological, clinical, 
dermoscopic, histopathological features ,  prognosis and evolving 
of   our population.
Materials and Methods
All cases of  acral melanoma were identified retrospectively be-
tween January 2009 and April 2014. For each patient, epidemio-
logical information (age, gender, medical history, sun exposure, 
previous trauma, disease duration before diagnosis), clinical, der-
moscopic, histological, therapeutic and outcome were recorded.
Results
We compiled 54 cases of  melanoma during the study period, 
31 patients had an acral location, which represents 57% of  all 
melanomas. The male to female ratio was 1/ 1.2, with a mean 
age at the time of  diagnosis of  61 (32-86). 80% of  patients were 
fitzpatrick’s skin type IV, without history of  excessive sun expo-
sure. Only 8 patients (25%) reported previous trauma. The notion 
of  manipulation was reported in 11 cases (35% of  patients). The 
most common site was the foot (87%), with one case of  melano-
ma of  the thumb and another of  the index. The pigmented form 
(77, 4%) and the exophytic one (35%) were predominant. The 
size varied from 0.5 to 12 cm. The average time to diagnosis was 
30 months (3 months-10 years). The most common dermoscopic 
features were: parallel ridge pattern, irregular diffuse pigmenta-
tion, polymorphous vessels, blue-white veil. The Breslow thikness 
was> 4mm in 35.4% of  cases and the most common histologi-
cal type was the acral lentiginous melanoma (38.7%). Metastases 
were found at diagnosis in 55% of  patients, dominated by the 
lung (67.7%) the lymph node (47.7%),bone and liver  (13%), and 
at last  brain and adrenal  metastases (6.54 %). 45% of  patients 
were classified as stage IV. The search for C-Kit mutation and 
sentinel lymph node were not performed in any of  our patients. 
Different treatments were given to patients depending on stage. 
Five patients died after an average time of  9,3 months, 12 patients 
were lost of   the follow immediately , and 12 patients after a mean 
follow up of  6 months.
Discussion
Melanoma is an aggressive malignancy whose incidence has in-
creased in worldwide in white populations, especially where fair-
skinned peoples receive excessive sun exposure over the last 20 
years. The acral melanoma is a rare variety which represents only 
2-13% of  all melanomas in Caucasians [2], however, this location 
is predominant in North Africa (more than 50% of  melanomas 
in Tunisia [3] and Algeria [4]) and sub-Saharan Africa; accord-
ing to the study of  Pitche et al [5];  63, 5% of  melanomas Togo 
are localized on the feet and 19% of  the hands, these results are 
similar to the figure of  57% found in our series, this location is 
also common in Asians (35-49%), Hispanic (20-34%) and African 
Americans (50-70%) [1,2,6,7].
The acral melanoma, like other subtypes of  melanoma is predom-
inant in female patients in caucasians  , the male/female ration  is 
1 / 1.6 [8]. However, this figure is a trend to be reversed in our 
country with a male / female ratio of  1.2 in our series, this result 
is also similar to those recorded in Tunisia (1.19) [3] and Togo 
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(1.03) [5]. In Asian male predominance is much sharper, with a 
sex ratio that exceeds 2 for all melanomas or 6 for acral melanoma 
[9,10]. The average age of  our patients was 61 years, which joins 
the data in the literature [8].
The acral melanoma occurs most often like a  black or brown 
macule with irregular edge, nodules, or exophytic tumors;  in our 
series, this last form was predominant,  because probably of   the 
diagnostic delay and self  manipulation;  which  also may partici-
pate in tumor dissemination (45% of  patients were classified stage 
IV (according to the sixth edition of  the pTNM classification of  
the International Union Against Cancer (UICC) and the Amer-
ican Joint Comittee on Cancer (AJCC)) and increased Breslow 
thickness (> 4mm in 35.4% in our series). Amelanotic malignant 
melanoma variety was found in 20% of  our patients; this form 
may mimic other entities such as pyogenic granuloma, poorly 
plantar wart or wound [11], which can participate in the diagnostic 
delay. The predominant histological type is the acral lentiginous 
melanoma which joined the literature data [3,8].
Unlike other types of  melanoma, sun exposure does not appear 
to play a role in acral melanoma, the concept of  trauma, long 
disputed, is currently controversial; in the retrospective study of  
Kaskel  [12], only  8,7% (32 patients) of  the patients   considered 
an association of  trauma and melanoma formation likely, of  these 
32 patients, 22 patients reported a single event, and 10 patients a 
persisting irritation. He concluded, that based on epidemiologi-
cal, clinical and scientific research to date, there seems to be no 
evidence of  the role of  trauma in the pathogenesis of  formation 
of  melanoma. 
Briggs [13] says that, if  trauma as a common event at acral sites 
is a cofactor for melanoma, then the incidence of  subungual and 
other acrolentiginous melanomas should consequently be higher. 
Several authors have pointed to the possibility that previous in-
juries were  coincidences recalled to the memory of  the patients 
during the subsequent appearance of  a tumor (recall bias) and 
that  secondary trauma have  played a revealing role in attracting 
the attention of  the patient or physician to a preexisting lesion. 
Moreover, this notion of  trauma was found in 8 cases in our se-
ries. [11].
Acral melanomas have a low incidence of  BRAF mutations but 
are more likely to harbor mutations of  KIT. KIT (CD117) en-
codes a tyrosine kinase receptor for the stem cell factor and plays 
a key role in melanocytic development, migration, and prolifera-
tion. It is the target of  several small molecule inhibitors such as 
imatinib and sunitinib, which are already used in the clinic and 
have significantly improved survival in gastrointestinal stromal 
tumor (GIST) patients with activating KIT mutations. A recently 
published study showed that imatinib significantly prolongs the 
lifespan of  patients with metastatic melanoma harboring KIT 
mutations [1].
C-KIT mutation is detected in approximately 23% to 36% [14,15] 
acral melanoma in Caucasians, it is less common among Asians, in 
the study of  Si et al [16] it is present in 11.9% of  acral melanomas.
It is always important to consider the C-KIT mutational status of  
acral melanoma in each ethnic group, to predict the effectiveness 
of  targeted therapies [17].
In our patients were given different treatments depending on the 
stage, the search for C-Kit mutation was not performed in any 
case, do not allow the use of  targeted therapies.
Conclusion
The acral melanoma is a very aggressive tumor whose incidence 
is increasing; a good knowledge of  these clinical presentations, 
an adequate care, as well as specific preventive messages   to our 
population may guarantee a better prognosis.
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